As one of the richest couples in the world, Mark Zuckerberg and Dr. Priscilla Chan have a lot of money to spend. However, even for the founder of Facebook, $3 billion is still a huge investment. That’s exactly how much they are pledging for the Chan Zuckerberg Initiative, however, which is meant to cure all of the world’s diseases.
As The New York Times reports, the wealthy couple had already committed 99 percent of their shares in Facebook to charity the previous year. This time, they are putting a solid number on how much they are willing to give to a good cause. The $3 billion will be spent on a decade-long crusade to rid the world of its most serious diseases.
The foundation had actually already contributed to multiple causes, including charter schools as well as startups that were related to education. However, the money that the couple is promising is the initiative’s first major impact when it comes to scientific efforts. Then again, curing diseases is more in line with what Dr. Chan specializes in since she is a trained pediatrician.
In a speech she made about the initiative, Dr. Chan described how the move would contribute to the advancement of human potential. She also spoke about the importance of high-quality education, using her case as an example of what it can do for disadvantaged people.
“We want to dramatically improve every life in Max’s generation and make sure we don’t miss a single soul. We’ll be investing in basic science research with the goal of curing disease,” Dr. Chan stated.
Max is actually the couple’s daughter whose full name is Maxima. It was when she was born that the couple decided to pursue charitable actions in earnest.
During the presentation, Mark Zuckerberg himself came out to explain exactly which diseases they plan to tackle with the initiative, Tech Crunch reports. Among the biggest targets listed include cancer, heart disease, neurological diseases, and infectious diseases.


Anthropic Officials Meet White House Over AI Model Outage
US Raises Concerns Over Possible ASML EUV Machine Transfer to China
OpenAI's $34B Spending Pushes AI Market Leadership Ahead of IPO
Samsung Gains Interest from BYD, Google, AMD as AI Chip Demand Strains TSMC Capacity
SoftBank Vision Fund CFO Navneet Govil to Exit After Decade-Long Tenure
G7 Explores AI Access Deal With U.S. Amid Anthropic Restrictions
SpaceX Stock Soars After Historic IPO, Reaches $2.5 Trillion Market Value
Google Gemini Co-Lead Noam Shazeer Leaves for OpenAI Amid AI Talent Race
Trump Administration Delays DeepSeek and CXMT Trade Blacklist Designations Amid U.S.-China Tensions
UK Banks Report Surge in APP Fraud Losses as Pressure Mounts on Meta and Tech Platforms
Meta AI Strategy Faces Challenges as Zuckerberg Admits Mistakes in Internal Memo
SpaceX IPO Set for Explosive Debut as Valuation Tops $2.2 Trillion
SK Hynix Shares Hit Record High After Shipping Next-Generation HBM4E AI Memory Samples
ByteDance Eyes Iluvatar, Baidu AI Chips Amid China’s AI Push 



